Meeting
2019 Gastrointestinal Cancers Symposium
Designing clinical trials in 3L+ pancreatic cancer.
Authors
Victoria G. Manax
PanCAN, Manhattan Beach, CA
Victoria G. Manax , Valery Chatikhine , Saundra Kirven , Ben R Taylor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Clinical Trial Registration Number
NCT03512756
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 226)
DOI
10.1200/JCO.2019.37.4_suppl.226
Abstract #
226
Poster Bd #
C2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Proactive assessment of patient reported outcomes in patients with ovarian cancer.
First Author: Ainhoa Madariaga
Poster
2023 ASCO Annual Meeting
Phase 3 PANOVA-3 study: Tumor treating fields (TTFields) therapy concomitant with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic cancer.
First Author: Hani M. Babiker
Poster
2022 ASCO Annual Meeting
A phase Ib/II study of sotorasib combined with chemotherapy for second-line treatment of KRAS p. G12C–mutated advanced pancreatic cancer.
First Author: Devalingam Mahalingam
Poster
2019 Gastrointestinal Cancers Symposium
Impact of glycemic control on treatment efficacy and safety during nabpaclitaxel plus gemcitabine therapy in unresectable pancreatic cancer.
First Author: Junko Tauchi